(3-Dimethylamino-phenoxy)-acetic acid, 98.0%, 250mg

[(R)-(+)-2,2�-bis(diphenylphosphino)-1,1�-binaphthyl][(1S,2S)-(-)-1,2-diphenylethylenediamine]RuCl2, 95%, 100mg

(S)-tert-Butyl 3-(bromomethyl)piperidine-1-carboxylate, 95.0%, 1g

GLICLAZIDE, 95%, 5g

Diphenyl(4-vinylphenyl)phosphine (stabilized with BHT)>98.0%(GC)25g

(2S,5S)-ethyl 5-hydroxypiperidine-2-carboxylate (2S,3S)-2,3-bis((4-methylbenzoyl)oxy)succinate, 98%, 100mg

tert-Butyl (R)-3-(4-iodo-1H-pyrazol-1-yl)pyrrolidine-1-carboxylate, 98%, 50mg

OXEPAN-4-OL, 95.0%, 250mg

Ambroxol Hydrochloride, 97.0%, 100g

N-[2-(4-HYDROXYPHENYL)ETHYL]METHANESULFONAMIDE, 95.0%, 100mg

(S)-tert-Butyl 3-(pyridin-2-yloxy)pyrrolidine-1-carboxylate, 95.0%, 250mg

CataCXium A Pd G3, ?98.0%, 5g

ethyl 1-(2,2,2-trifluoroethyl)-1H-pyrazole-3-carboxylate, 97%, 10g